Speakers
Dr Annemarie Docherty
Professor Gavin Perkins
Dr Stephen Webb
Alex Warren
Stream 2
This session delivers cutting-edge updates in both clinical and academic aspects of cardiology in the intensive care setting. It brings together national experts to explore the latest research, evolving treatment guidelines, and real-world data that are shaping the future of cardiac care in critical illness. It will start with a review of the latest evidence relating to the treatment of cardiac arrest, drawing on the findings and implications of recent research and updates from the International Liaison Committee on Resuscitation Consensus on Science and Treatment Recommendations. The focus will then shift to explore the different types of myocardial Infarction (MI) and why we should be concerned about Type 2 MIs which we see commonly in ICU. The talk will cover who is at risk, how best to diagnose and manage it, and what outcomes to expect. We then move to the management of obstetric patients with complex cardiac conditions, highlighting practical approaches and multidisciplinary considerations for all critical care teams. And finally the session will end with a description and early data from an ICNARC-led study on epidemiology, management, and outcomes of cardiogenic shock, offering new perspectives and future directions for intensive care clinicians. Learning objectives
1. Review the latest evidence and updates in the management of cardiac arrest.
2. Explore diagnosis, management and outcome of patients with type 2 MI in critical care settings.
3. Understand the management of obstetric patients with complex cardiac conditions.
4. Recognise the role of data collection in improving care for patients with cardiogenic shock.
Chairpersons Carla Richardson and Stephen Webb
Gavin Perkins
Key updates in managing cardiac arrest
Annemarie Docherty
Type 2 MI in ICU – is it important?
Catriona Bhagra
Managing cardiac disease in obstetric patients
Alex Warren
ICNARC / QMUL Insights from new data — the ICNARC Cardiogenic Shock Module.
Annemarie leads ICU-HEART. This multi-disciplinary collaboration aims to revolutionise the care of Intensive Care patients by harnessing novel approaches in the use of technology and high dimensional data. Our two exemplar projects - diagnosis of myocardial infarction, and multimorbidity - combine key unanswered research priorities with the need for data driven innovation.
Prof Gavin Perkins is Dean of Medicine at Warwick Medical School, University of Warwick, Honorary Professor of Critical Care Medicine at University Hospitals Birmingham and Non-Executive Director at University Hospitals Coventry and Warwickshire. He has published over 500 papers and played a key role in developing the evidence base relating to cardiac arrest through his leadership of the UK National Out of Hospital Cardiac Arrest Outcomes Registry and the PARAMEDIC trials (PARAMEDIC-1, mechanical CPR, PARAMEDIC-2, adrenaline for cardiac arrest; PARAMEDIC-3 IV versus IO access) as well as research on CPR Feedback and Debriefing. Working with colleagues from across the UK, he played a key role in the underpinning research which informed the Recommended Emergency Care Treatment Plans (ReSPECT). His contribution to clinical research has been recognised through election as a Fellow to the Academy of Medical Sciences, appointment as a National Institute for Health Research Senior Investigator, honorary membership of the Resuscitation Council UK, European Resuscitation Council and Intensive Care Society and recognition as a Resuscitation Giant by the International Liaison Committee on Resuscitation. Clarivate have identified him as a highly cited researcher, ranking in the top 1% of scientists in the world. As a Masters graduate in Medical Education, Prof Perkins prides himself in the organisation and delivery of high quality, research-led teaching to students and healthcare professionals at Warwick and around the world. Although his role now primarily focuses on leadership he has led the development of novel undergraduate and postgraduate teaching which had an impact on thousands of students and the patients they treat. Prior to taking up the role of Dean he served as Director of Warwick Clinical Trials Unit, Director of Research for the Intensive Care Society and as a MERIT Consultant with West Midlands Ambulance Service for which he received the Queens Jubilee Medals for Pre-hospital Care.
Dr Webb is a Consultant in Intensive Care at Royal Papworth Hospital Cambridge. His
clinical, education and research interests lie in cardiothoracic intensive care, severe acute
respiratory failure, advanced heart failure and cardiogenic shock, clinical adult and quality
improvement. Dr Webb’s management roles at Royal Papworth Hospital include
Responsible Officer and Deputy Medical Director. He is am also Human Tissue Authority
(HTA) Designated Individual at Royal Papworth Hospital and Member of the Council of
Governors for Cambridge University Hospitals.
Dr Webb’s current national roles include Medical Practitioners Tribunal Service (MPTS)
Committee Member & Suitable Person, Special Advisor to the UK Intensive Care Society
(ICS) Council, Chair of the UK MEDUSA Injectable Medicines Guide Advisory Board,
Chair of the UK Critical Care Leadership Forum (CCLF) and Regional Committee
Member of the Advisory Committee for Clinical Impact Awards (ACCIA).
Dr Webb graduated in Medicine from Queen's University Belfast in 1999 and undertook
postgraduate specialist medical training in Anaesthesia and Intensive Care Medicine in
Northern Ireland and Cambridge. He was appointed as Consultant in Anaesthesia &
Intensive Care Medicine at Royal Papworth Hospital Cambridge in 2008.
In the past Dr Webb has worked with several healthcare organisations and held various
roles. Previous positions include President of the UK Intensive Care Society (ICS),
Clinical Lead of the Eastern Academic Health Science Network (EAHSN) Patient Safety
Collaborative and Member of the East of England Clinical Senate Council. Dr Webb has
also worked with the Royal College of Physicians (RCP), Care Quality Commission
(CQC), Faculty of Medical Leadership and Management (FMLM), Intensive Care National
Audit & Research Centre (ICNARC), The Health Foundation, National Institute for Health
and Care Excellence (NICE) and The National Confidential Enquiry into Patient
Outcomes and Deaths (NCEPOD).
Alex is an NIHR Doctoral Fellow at ICNARC, PhD candidate at Queen Mary University London and an ICU registrar at St Bartholomew’s Hospital. He attended medical school at Guy’s, King’s and St Thomas’ with a brief interlude in Glasgow for his intercalated degree, before working in Cambridge, Edinburgh and Auckland and finally returning to London. He is interested in all aspects of cardiac critical care, particularly cardiogenic shock and out-of-hospital cardiac arrest. His current research enhances routinely collected critical care audit data from the ICNARC Case Mix Programme to characterise the epidemiology and outcomes of patients with cardiogenic shock across the UK, identify variation in management, and create hypotheses for testing in future interventional studies.
Dr Carla Richardson is a Consultant Intensivist and Anaesthetist at University Hospital Birmingham and she is the lead for ecmo and ultrasound in critical care. She is also a pre hospital doctor and works as a MERIT Consultant with the West Midlands Ambulance Service.
She trained in the West Midlands, with Sydney HEMS, Australia and Guys and St Thomas Hospital in London.
Her clinical interests include respiratory failure, cardiogenic shock and mechanical circulatory support, cardiac critical care and point of care ultrasound.